People with diabetes have been reported to have more severe outcomes, as comparedwith non-diabetic people, with severe acute respiratory syndrome coronavirus 2...
Cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfectionhave been reported in Hong Kong, Belgium, the Netherlands, and the USA.1–4 Here...
To the best of our knowledge, no longitudinal study has reported the kinetics of severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody responses...
Taking safety, immunogenicity, and production capacity into account, the 3 μg doseof CoronaVac is the suggested dose for efficacy assessment in future phase 3 trials....
The COVID-19 pandemic presents particular challenges for people with intellectualdisability.1 Individuals with Down syndrome, the most common form of intellectual...
We congratulate Giacomo Grasselli and colleagues1 on their work in comparing acuterespiratory distress syndrome (ARDS) in COVID-19 with classical ARDS. They found...
Cellular senescence is hypothesised as a major driving force in IPF and COPD; telomereshortening might be a contributory factor in IPF, suggesting divergent mechanisms...
Early ECMO-facilitated resuscitation for patients with OHCA and refractory ventricularfibrillation significantly improved survival to hospital discharge compared...
We read with great interest the Article by the COVIDSurg Collaborative.1 It is nowrecognised that patients diagnosed with COVID-19 have a higher risk of venous...
COVID-19 patients, in particular those with severe respiratory complications, mayhave high postoperative mortality. Medical staff in close contact with infected...